Linearis , with its tandem Ventures Fund and Laboratory, is pioneering and supporting discoveries through direct investments in innovative AI-powered life sciences companies
Linearis is transforming healthcare by merging artificial intelligence and biomarker analysis to enhance patient care with more precise, accessible prevention, detection, treatment of metabolic diseases including cancer, diabetes, and antimicrobial resistance.